These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

524 related articles for article (PubMed ID: 20061466)

  • 61. Food for thought ... on alternative methods for nanoparticle safety testing.
    Hartung T
    ALTEX; 2010; 27(2):87-95. PubMed ID: 20686741
    [No Abstract]   [Full Text] [Related]  

  • 62. A review of the status of alternative approaches to animal testing and the development of integrated testing strategies for assessing the toxicity of chemicals under REACH--a summary of a DEFRA-funded project conducted by Liverpool John Moores University and FRAME.
    Grindon C; Combes R; Cronin MT; Roberts DW; Garrod J
    Altern Lab Anim; 2006 Mar; 34 Suppl 1():149-58. PubMed ID: 16555968
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Alternative methods for developmental toxicity testing.
    Piersma AH
    Basic Clin Pharmacol Toxicol; 2006 May; 98(5):427-31. PubMed ID: 16635099
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Commentary on "Toxicity testing in the 21st century: implications for human health risk assessment" by Krewski et al.
    Conolly RB
    Risk Anal; 2009 Apr; 29(4):480-1; discussion 492-7. PubMed ID: 19076324
    [No Abstract]   [Full Text] [Related]  

  • 65. A toxicology for the 21st century--mapping the road ahead.
    Hartung T
    Toxicol Sci; 2009 May; 109(1):18-23. PubMed ID: 19357069
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Green chemistry, polymers of low concern, and animal testing and welfare.
    Conaway CC
    Toxicol Mech Methods; 2011 Oct; 21(8):569-70. PubMed ID: 21943231
    [No Abstract]   [Full Text] [Related]  

  • 67. The long and winding road of progress in the use of in vitro data for risk assessment purposes: From "carnation test" to integrated testing strategies.
    Blaauboer BJ
    Toxicology; 2015 Jun; 332():4-7. PubMed ID: 24769060
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The role of ICCVAM in evaluating new and alternative test methods.
    Stokes WS; Hill RN
    Lab Anim (NY); 2002; 31(7):26-32. PubMed ID: 12200591
    [No Abstract]   [Full Text] [Related]  

  • 69. Biologically relevant exposure science for 21st century toxicity testing.
    Hubal EA
    Toxicol Sci; 2009 Oct; 111(2):226-32. PubMed ID: 19602574
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Novel strategies for toxicological risk assessments.
    Roy A; Akbarsha MA
    ALTEX; 2014; 31(1):91-3. PubMed ID: 24448760
    [No Abstract]   [Full Text] [Related]  

  • 71. Moving from rats to cellular omics in regulatory toxicology: great challenge toward sustainability or "up-shit-creek without a paddle"?
    Tralau T; Luch A
    Arch Toxicol; 2015 Jun; 89(6):819-21. PubMed ID: 25820918
    [No Abstract]   [Full Text] [Related]  

  • 72. Integrated decision-tree testing strategies for skin corrosion and irritation with respect to the requirements of the EU REACH legislation.
    Grindon C; Combes R; Cronin MT; Roberts DW; Garrod JF
    Altern Lab Anim; 2008 Oct; 36 Suppl 1():65-74. PubMed ID: 19025332
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Toxicology. House would foil human pesticide studies.
    Kaiser J
    Science; 2005 May; 308(5726):1234. PubMed ID: 15919959
    [No Abstract]   [Full Text] [Related]  

  • 74. An assessment of progress in the use of alternatives in toxicity testing since the publication of the report of the second FRAME Toxicity Committee (1991).
    Combes R; Balls M; Bansil L; Barratt M; Bell D; Botham P; Broadhead C; Clothier R; George E; Fentem J; Jackson M; Indans I; Loizu G; Navaratnam V; Pentreath V; Phillips B; Stemplewski H; Stewart J
    Altern Lab Anim; 2002; 30(4):365-406. PubMed ID: 12234245
    [No Abstract]   [Full Text] [Related]  

  • 75. Metabolism: a bottleneck in in vitro toxicological test development. The report and recommendations of ECVAM workshop 54.
    Coecke S; Ahr H; Blaauboer BJ; Bremer S; Casati S; Castell J; Combes R; Corvi R; Crespi CL; Cunningham ML; Elaut G; Eletti B; Freidig A; Gennari A; Ghersi-Egea JF; Guillouzo A; Hartung T; Hoet P; Ingelman-Sundberg M; Munn S; Janssens W; Ladstetter B; Leahy D; Long A; Meneguz A; Monshouwer M; Morath S; Nagelkerke F; Pelkonen O; Ponti J; Prieto P; Richert L; Sabbioni E; Schaack B; Steiling W; Testai E; Vericat JA; Worth A
    Altern Lab Anim; 2006 Feb; 34(1):49-84. PubMed ID: 16522150
    [No Abstract]   [Full Text] [Related]  

  • 76. Predictive toxicology today: the transition from biological knowledge to practicable models.
    Benigni R
    Expert Opin Drug Metab Toxicol; 2016 Sep; 12(9):989-92. PubMed ID: 27351633
    [No Abstract]   [Full Text] [Related]  

  • 77. Strategies to replace in vivo acute systemic toxicity testing. The report and recommendations of ECVAM Workshop 50.
    Gennari A; van den Berghe C; Casati S; Castell J; Clemedson C; Coecke S; Colombo A; Curren R; Dal Negro G; Goldberg A; Gosmore C; Hartung T; Langezaal I; Lessigiarska I; Maas W; Mangelsdorf I; Parchment R; Prieto P; Sintes JR; Ryan M; Schmuck G; Stitzel K; Stokes W; Vericat JA; Gribaldo L;
    Altern Lab Anim; 2004 Oct; 32(4):437-59. PubMed ID: 15651930
    [No Abstract]   [Full Text] [Related]  

  • 78. Animal tests inescapable.
    Nature; 2008 May; 453(7195):563-4. PubMed ID: 18509386
    [No Abstract]   [Full Text] [Related]  

  • 79. The integrated project ReProTect: a novel approach in reproductive toxicity hazard assessment.
    Hareng L; Pellizzer C; Bremer S; Schwarz M; Hartung T
    Reprod Toxicol; 2005; 20(3):441-52. PubMed ID: 15899576
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Toxicity testing moves from the legislature to the petri dish-and back.
    Gura T
    Cell; 2008 Aug; 134(4):557-9. PubMed ID: 18724925
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.